Keynote Presentation: Highlighting Myeloid’s Groundbreaking Clinical Experience with the First In Vivo CARs Applied to Humans
Time: 11:00 am
day: Day One
Details:
- Exploring CAR designs to target myeloid, NK, and T cells to enhance therapeutic precision when combating solid tumors
- Leveraging LNP technology to create a scalable, accessible, cost-effective platform
- Uncovering first-in-class phase 1 clinical trial data, demonstrating safety promising clinical benefits
